SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AMC Robotics Corp. engages in developing and deploying AI-enabled robotics and smart security solutions, especially for warehouse automation, enterprise security, robotics patrol/incident-response and logistics automation. The company is headquartered in New York, NY.

AMC Robotics Corp.

AMCI is trending due to speculation of a potential short squeeze, with community members actively discussing strategies to push the stock higher and liquidate shorts. The stock's high volatility and recent price action are fueling the conversation, as traders compare it to other low-float stocks that have experienced significant surges. Some are noting the company's small market cap and low float, which could contribute to rapid price movements.

Radiopharm Theranostics Ltd. operates as a pre-clinical and clinical research company. It focuses on the development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical need. The company is founded by Paul A. Hopper in 2021 headquartered Carlton, Australia.

Radiopharm Theranostics Ltd - ADR

RADX is trending due to positive interim data from its Phase 2b trial, showing promising results in brain metastases imaging, with the community actively discussing the potential for a short squeeze and anticipating further details from an upcoming webinar. The stock's high trading volume and significant pre-market gains are fueling speculative interest, despite some concerns about potential pullbacks and short attacks. This surge is also drawing attention to the broader oncology radiopharmaceutical sector.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is trending downwards, driven by sector-wide concerns about an AI bubble and delayed data center projects, despite a major Microsoft deal. Community sentiment is divided, with some calling the stock a "scam" and expecting further declines, while others view the dip as a buying opportunity, citing strong fundamentals and long-term growth potential. Discussions also revolve around potential market manipulation and the stock's correlation with Bitcoin's price movements.

Click Holdings Ltd. operates as a holding company which provides temporary and permanent personnel solutions. Its services include professional solution services, nursing solution services, and logistics and other solution services. The company was founded by Chun Sing Chan on January 31, 2024 and is headquartered in Hong Kong.

Click Holdings Ltd. - Ordinary Shares - Class A

Click Holdings Limited

CLIK is trending due to chatter around its low float and potential for a significant price surge, with some comparing it to other recent low-float runners. Discussions also involve the company's fundamentals, potential news catalysts, and high borrow rate, leading to speculation about a possible short squeeze. Some traders are moving profits from other stocks into CLIK, anticipating a substantial upward movement.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray is trending amid speculation around potential cannabis rescheduling following comments from President Trump, sparking high volatility. The community is debating the likelihood and timing of an executive order, with some anticipating a short squeeze, while others express skepticism and caution against "pump and dump" schemes. Overall, the discussion reflects a mix of hope and uncertainty surrounding the future of cannabis regulation.

Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also focuses on immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective medicines with optimal therapeutic benefit. The company was founded in 1990 and is headquartered in San Francisco, CA.

Nektar Therapeutics

Nektar Therapeutics is trending as investors anticipate data and potential catalysts related to its immunology pipeline. Community discussions revolve around upcoming conference calls, data releases, and speculation about a potential buyout, particularly concerning the ongoing litigation with Eli Lilly. Traders are also actively monitoring technical indicators and analyst price targets, contributing to the increased attention surrounding NKTR.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal is trending as community members discuss the company's application to become a bank, potentially expanding its services to include small business loans and savings accounts.  Some see this as a game-changer with Federal Reserve backing and potential for long-term growth, while others express concern about a possible shift to a bank-hybrid multiple. Discussions also include the potential impact on revenue streams and comparisons to other financial institutions.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow is trending amid discussions about its valuation and potential acquisitions, with community members weighing the impact of AI on its business model. Some investors express frustration with the stock's recent performance despite strong earnings, while others see it as an undervalued AI play with long-term growth potential. The community is also closely watching for a potential stock split and its impact on the share price.

Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA.

Artiva Biotherapeutics Inc

ARTV is trending due to FDA's Fast Track designation for its AlloNK therapy targeting refractory rheumatoid arthritis, a significant milestone sparking community enthusiasm. Discussions center on the potential for accelerated development and market entry, with some cautioning about potential offerings. Wedbush's increased price target adds to the bullish sentiment, as traders weigh the news' long-term implications.

Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis and cannabis-derivative products. It operates through the Cannabis and Plant Propagation segments. The company was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.

Aurora Cannabis Inc

Aurora Cannabis is trending as investors closely monitor potential shifts in cannabis policy, particularly after Trump hinted at reclassification, sparking community discussions around executive orders and rescheduling timelines. Community members express a mix of anticipation and skepticism, referencing past disappointments and the broader implications for the cannabis sector. Bullish investors are hoping for a sustained rally, while bears remain cautious.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Marex Group plc Buys New Holdings in Madrigal Pharmaceuticals, Inc. $MDGL

Marex Group plc purchased a new position in shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) during the second quarter, according to the company in its most recent Form 13F filing...

Insider Selling: Madrigal Pharmaceuticals (NASDAQ:MDGL) Director Sells 24,800 Shares of Stock

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Get Free Report) Director Paul Friedman sold 24,800 shares of Madrigal Pharmaceuticals stock in a transaction on Wednesday, December 10th. The shares...

Madrigal Pharmaceuticals (NASDAQ:MDGL) Director Sells $10,297,597.50 in Stock

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Get Free Report) Director Rebecca Taub sold 18,650 shares of Madrigal Pharmaceuticals stock in a transaction that occurred on Wednesday, December 10th...

Madrigal Pharmaceuticals (NASDAQ:MDGL) Director Rebecca Taub Sells 18,650 Shares

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Get Free Report) Director Rebecca Taub sold 18,650 shares of the stock in a transaction on Wednesday, December 10th. The stock was sold at an average...

Braidwell LP Has $18.40 Million Holdings in Madrigal Pharmaceuticals, Inc. $MDGL

Braidwell LP boosted its holdings in shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) by 24.8% during the 2nd quarter, according to the company in its most recent disclosure with...

Madrigal Pharmaceuticals, Inc. $MDGL is Paulson & CO. Inc.'s Largest Position

Paulson & CO. Inc. cut its stake in shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) by 0.5% during the second quarter, according to the company in its most recent filing with the...

Madrigal Pharmaceuticals, Inc. $MDGL Holdings Increased by Stempoint Capital LP

Stempoint Capital LP boosted its stake in shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) by 28.7% during the 2nd quarter, according to its most recent disclosure with the...

Norges Bank Invests $53.41 Million in Madrigal Pharmaceuticals, Inc. $MDGL

Norges Bank purchased a new stake in shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) during the second quarter, according to the company in its most recent 13F filing with the...

JPMorgan Chase & Co. Buys 27,840 Shares of Madrigal Pharmaceuticals, Inc. $MDGL

JPMorgan Chase & Co. increased its stake in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) by 99.4% during the 2nd quarter, according to its most recent disclosure with the Securities and...

Insider Selling: Madrigal Pharmaceuticals (NASDAQ:MDGL) CEO Sells 2,400 Shares of Stock

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Get Free Report) CEO William John Sibold sold 2,400 shares of the business's stock in a transaction that occurred on Thursday, December 4th. The stock...

Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. The company was founded by Rebecca A. Taub, Frederick Bernard Craves, and Edward Chiang on March 10, 2000 and is headquartered in West Conshohocken, PA.

Current Price	$560.55
Prev Close	$571.44
Open	$571.84
Dividend Yield	0.00%
50-Day Moving Average	$496.62
Beta	0.75
Avg. Volume	451,586.79
PE Ratio	-43.93

52-Week High	$605.00
52-Week Low	$265.00
Market Capitalization	$12.98B
EPS (Annual)	-$21.90
Price to Book	20.73
Revenue Per Employee	$341,160.98
Enterprise Value/EBITDA	N/A

MDGL
Madrigal Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest MDGL News

MDGLMadrigal Pharmaceuticals Inc